Innate immune epigenomic landscape following controlled human influenza virus infection
RNA-seq (gene expression) · human · 755 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 755 samples: 755 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Innate immune molecular landscape following controlled human influenza virus infectionCell reports · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE299820_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1276569 and SRA study SRP592061. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from the first 400 of 755 sample titles: 400 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9046530 002758a3d112d3b1;MVA-NP+M1
- GSM9046531 0056cd3b25759d67;PLACEBO
- GSM9046532 006c1ffe74d25779;MVA-NP+M1
- GSM9046533 007d361bbbaa0f0e;MVA-NP+M1
- GSM9046534 009fd7380abe4bc9;PLACEBO
- GSM9046535 015aca736e7f72ca;PLACEBO
- GSM9046536 0187ef0ed3d8e480;PLACEBO
- GSM9046537 022f93c976ffa227;MVA-NP+M1
- GSM9046538 02978ad977ba5956;PLACEBO
- GSM9046539 02eb9f2a99714382;MVA-NP+M1
- GSM9046540 033173d5ba0d7740;PLACEBO
- GSM9046541 03356cac9ead2d01;MVA-NP+M1
- GSM9046542 03a388c3810c13ad;MVA-NP+M1
- GSM9046543 03ad899c27769efd;MVA-NP+M1
- GSM9046544 04647d61b617cc48;MVA-NP+M1
- GSM9046545 04803d20b3673502;MVA-NP+M1
- GSM9046546 04e4f62d9bf4312d;MVA-NP+M1
- GSM9046547 04fdbee96b2f481c;MVA-NP+M1
- GSM9046548 058abb1d9ac129aa;MVA-NP+M1
- GSM9046549 05b925b49f2c5d5c;MVA-NP+M1
- GSM9046550 05e1bbe87158bfb8;PLACEBO
- GSM9046551 061455084e2d2691;PLACEBO
- GSM9046552 0640e05f437dcbf3;PLACEBO
- GSM9046553 06572c2f69e913fb;MVA-NP+M1
- GSM9046554 06e4c24e47ce5df2;MVA-NP+M1
- GSM9046555 0747f3fbb31dd106;MVA-NP+M1
- GSM9046556 0789448ff8f6c49c;MVA-NP+M1
- GSM9046557 081c04b0b4542c9b;MVA-NP+M1
- GSM9046558 084a8cd1616beb02;MVA-NP+M1
- GSM9046559 089d687a754370dc;MVA-NP+M1
- GSM9046560 09c09356b26dfcde;MVA-NP+M1
- GSM9046561 09cf8937ebfbba4d;MVA-NP+M1
- GSM9046562 0b1aced867721eb3;MVA-NP+M1
- GSM9046563 0b5c1e9933cf80fb;MVA-NP+M1
- GSM9046564 0baf9ba5e9f23cd3;MVA-NP+M1
- GSM9046565 0c18067bcba2ab20;MVA-NP+M1
- GSM9046566 0c8745b41b897fee;PLACEBO
- GSM9046567 0cbf1e04801d6422;MVA-NP+M1
- GSM9046568 0ccdb3d92d944be4;MVA-NP+M1
- GSM9046569 0d37fe6299d3eeb8;PLACEBO
+ 715 more — browse all 755 samples with per-sample file links →
- GSE309140 Enhanced interferon-stimulated gene signatures in B cells following influenza B virus infection compared to influenza vaccination 16 samples shares following, influenza, virus
- GSE286042 Transcriptomic and Proteomic Signatures Following AS03-adjuvanted Influenza A/H7N9 Vaccine 1232 samples shares following, influenza
- GSE283403 Influenza virus exposure shapes the B cell response to influenza vaccination fifty years later 90 samples shares influenza, virus
- GSE252145 Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial 32 samples shares controlled, following
- GSE290866 Programmable mRNA Therapeutics for Controlled Epigenomic Modulation of Single and Multiplexed Gene Expression in Diverse Diseases (human data) 20 samples shares epigenomic, controlled
- GSE262861 Improvement of immune dysregulation and health-related quality of life in individuals with long COVID at 24-months following SARS-CoV-2 infection 11 samples shares following
- GSE313156 Temporal modulation of gene expression in a controlled Schistosoma mansoni human infection model 144 samples shares controlled
- GSE313527 Plasma Extracellular Vesicle Modulate Immune Cell Transcriptional Responses Following Acute Myocardial Infarction 74 samples shares following
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.